Sandoz Private Limited Tacrolimus Export Data — India (DGFT 2022–2026)

Name: Sandoz Private Limited Tacrolimus Export Records India — #1 Exporter, 737 Shipments, $36.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tacrolimus

India Pharmaceutical Trade Intelligence

$201.2M299 Suppliers127 CountriesHS 30049099

ExportsIndia → UNITED STATES54.1%India → SLOVENIA11.9%

ImportsIRELAND → India$38.9M GERMANY → India$3.6M

#1 Supplier: SANDOZ PRIVATE #1 Buyer: ASCEND LABORATORIES

Sandoz Private Limited — Tacrolimus Exporter #1 | $36.9M Trade Value | TransData Nexus | TransData Nexus

Sandoz Private Limited — Tacrolimus Exporter Profile

Indian Pharmaceutical Exporter · #1 for Tacrolimus · $36.9M export value · DGFT Verified

Sandoz Private Limited is the #1 Indian exporter of Tacrolimus with $36.9M in export value and 737 verified shipments. Sandoz Private Limited holds a 18.3% market share in Tacrolimus exports across 14 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.

Sandoz Private Limited — Tacrolimus Export Profile: Buyers & Destinations

Sandoz Private Limited Tacrolimus export treemap — buyers and destination countries | TransData Nexus

Where Does Sandoz Private Limited Export Tacrolimus?

Country	Value	Shipments	Share
UNITED STATES	$14.3M	293	47.7%
SLOVENIA	$8.8M	251	29.2%
AUSTRALIA	$2.2M	52	7.2%
CANADA	$1.9M	42

Who Are the Top Buyers of Tacrolimus from Sandoz Private Limited?

Buyer	Country	Value	Orders
SANDOZ INC. C/O EXEL, INC.	UNITED STATES	$9.3M	191
LEK D.D	SLOVENIA	$6.7M	196
SANDOZ INC C O EXEL INC	UNITED STATES	$4.9M	99
SANDOZ PTY LTD	AUSTRALIA	$1.5M	37
SANDOZ CANADA INC. C/O UPS SCS	CANADA	$1.4M	33
LEK D D PAKIRNI CENTER LENDAVA TRIMLINI	SLOVENIA	$905.3K	20
LEK D D	SLOVENIA	$833.0K	17
NOVARTIS ARGENTINA S.A.	ARGENTINA	$702.8K	15
SANDOZ PTY LTD.	AUSTRALIA	$478.9K	11
MURRY SA	URUGAY	$386.2K	10

Sandoz Private Limited supplies Tacrolimus to 45 buyers globally. The largest buyer is SANDOZ INC. C/O EXEL, INC. (UNITED STATES), followed by LEK D.D (SLOVENIA) and SANDOZ INC C O EXEL INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tacrolimus Formulations Does Sandoz Private Limited Export?

Product Description / Formulation	Value	Shipments
TACROLIMUS 1MG 100HGC BO US MATERIAL NO.	$5.2M	105
TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293	$3.0M	60
TACROLIMUS 0.5MG 100HGC BO US MATERIAL N	$1.3M	26
TACROLIMUS 0.5MG 100HGC BO US MATERIAL NO. - 44010291	$956.4K	22
TACROLIMUS HGC 1MG IN91 SH EU 04 MATERIAL NO. - 42031180	$876.1K	19
TACROLIMUS HGC 1MG IN91 SH EU 04 MATERIA	$550.0K	11
TACROLIMUS HGC 5MG IN91 SH EU 03 (DATA LOGGER AS PER INVOICE) (MATERIAL NO. - 42031157)	$534.6K	11
TACROLIMUS 1MG 100HGC BO US MATERIAL NO 44010293	$500.0K	10
TACROLIMUS SDZ 1MG 100HGC AUN MATERIAL N	$350.0K	7
MATERIAL NO- 44010293 TACROLIMUS 1MG 100HGC BO US	$350.0K	7

Sandoz Private Limited exports 278 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TACROLIMUS 1MG 100HGC BO US MATERIAL NO. with 105 shipments worth $5.2M.

How Does Sandoz Private Limited Compare to Nearest Tacrolimus Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SANDOZ PRIVATE LIMITED ★	$36.9M	737	14	$50.0K
4	INTAS PHARMACEUTICALS LIMITED	$22.5M	588	13	$38.2K
2	ALKEM LABORATORIES LIMITED	$8.4M	168	3	$50.0K

Sandoz Private Limited ranks #1 among 299 Indian Tacrolimus exporters. Average shipment value of $50.0K compared to the market average of $309.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Tacrolimus Exports?

Port	Shipments	% Share
SAHAR AIR	741	16.1%
SAHAR AIR CARGO ACC (INBOM4)	645	14.0%
DELHI AIR CARGO ACC (INDEL4)	398	8.6%
NHAVA SHEVA SEA (INNSA1)	358	7.8%
DELHI AIR	320	6.9%
AHEMDABAD AIR ACC (INAMD4)	175	3.8%
JNPT/ NHAVA SHEVA SEA	169	3.7%
Bombay Air	141	3.1%

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Tacrolimus Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.

Sandoz Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.

The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 737 individual customs records matching Sandoz Private Limited exporting Tacrolimus, covering 278 formulations to 15 countries via 45 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 127+ countries, 727+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tacrolimus

Tacrolimus

Sandoz Private Limited — Tacrolimus Exporter Profile

Sandoz Private Limited — Tacrolimus Export Profile: Buyers & Destinations

Where Does Sandoz Private Limited Export Tacrolimus?

Who Are the Top Buyers of Tacrolimus from Sandoz Private Limited?

What Is India's Total Tacrolimus Export Value and How Much Does Sandoz Private Limited Contribute?

What Is the Average Shipment Value for Sandoz Private Limited's Tacrolimus Exports?

How Does Sandoz Private Limited Compare to Other Indian Tacrolimus Exporters?

What Tacrolimus Formulations Does Sandoz Private Limited Export?

Regulatory Requirements: Exporting Tacrolimus to Key Markets

United States — FDA

Australia — TGA

How Does Sandoz Private Limited Compare to Nearest Tacrolimus Exporters?

Which Indian Ports Ship Tacrolimus Exports?

What Other Immunosuppressants Products Does Sandoz Private Limited Export?

Tacrolimus — Export Intelligence Video

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Tacrolimus Exports

Sandoz Private Limited — Regulatory Compliance & Quality Standards

About Sandoz Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tacrolimus Export Data from Sandoz Private Limited

Tacrolimus Stats

Company Overview

Top Products by Sandoz Private Limited

Related Analysis

Need Detailed Export Data?

Data Source